Yhlo Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
1,664
- Stock Symbol
-
688575
- Investments
-
10
- Share Price
-
$1.43
- (As of Friday Closing)
Yhlo General Information
Description
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
Contact Information
Website
www.szyhlo.comCorporate Office
- No. 65, Baolong 2nd Road
- Baolong Street, Longgang District
- Shenzhen, Guangdong 518116
- China
Corporate Office
- No. 65, Baolong 2nd Road
- Baolong Street, Longgang District
- Shenzhen, Guangdong 518116
- China
Yhlo Stock Performance
As of 20-Nov-2026, Yhlo’s stock price is $1.43. Its current market cap is $816M with 571M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.43 | $1.52 | $1.23 - $2.43 | $816M | 571M | 10.8M | $0.03 |
Yhlo Financials Summary
As of 30-Sep-2026, Yhlo has a trailing 12-month revenue of $283M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 938,138 | 1,218,061 | 1,278,782 | 1,839,329 |
| Revenue | 283,296 | 251,779 | 280,347 | 290,196 |
| EBITDA | 29,605 | 55,773 | 78,913 | 73,931 |
| Net Income | 15,446 | 3,246 | 42,023 | 50,180 |
| Total Assets | 647,106 | 612,965 | 604,799 | 536,930 |
| Total Debt | 131,224 | 128,048 | 124,079 | 78,662 |
Yhlo Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Yhlo Signals
Yhlo Investments & Acquisitions (10)
Yhlo’s most recent deal was a Later Stage VC with E-Health Now. The deal was made on 02-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| E-Health Now | 02-Mar-2026 | Later Stage VC | Practice Management (Healthcare) | ||
| Longlight | 08-Oct-2024 | Later Stage VC | Discovery Tools (Healthcare) | ||
| Shanghai Zhenxi | 08-May-2024 | Corporate | Laboratory Services (Healthcare) | ||
| Yahuilong Biotechnology | 09-Nov-2022 | Merger/Acquisition | Diagnostic Equipment | ||
| Rayertech | 30-Sep-2022 | Corporate | Therapeutic Devices |
Yhlo ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
34.98 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,999
Rank
Percentile
Healthcare
Industry
of 665
Rank
Percentile
Medical Devices
Subindustry
of 235
Rank
Percentile
Yhlo Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Yahuilong Biotechnology | Nanjing, China | 2001 |
Yhlo FAQs
-
When was Yhlo founded?
Yhlo was founded in 2008.
-
Where is Yhlo headquartered?
Yhlo is headquartered in Shenzhen, China.
-
What is the size of Yhlo?
Yhlo has 1,664 total employees.
-
What industry is Yhlo in?
Yhlo’s primary industry is Diagnostic Equipment.
-
Is Yhlo a private or public company?
Yhlo is a Public company.
-
What is Yhlo’s stock symbol?
The ticker symbol for Yhlo is 688575.
-
What is the current stock price of Yhlo?
As of 20-Nov-2026 the stock price of Yhlo is $1.43.
-
What is the current market cap of Yhlo?
The current market capitalization of Yhlo is $816M.
-
What is Yhlo’s current revenue?
The trailing twelve month revenue for Yhlo is $283M.
-
What is Yhlo’s annual earnings per share (EPS)?
Yhlo’s EPS for 12 months was $0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process